Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte) (LEPTO3)
Multicenter, Randomized, Open-label Non-inferiority Trial, Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte)
Sponsor: Centre Hospitalier Universitaire de la Réunion
This PHASE4 trial investigates Mild Leptospirosis and is currently actively recruiting participants. Centre Hospitalier Universitaire de la Réunion leads this study, which shows 9 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Not Yet Recruiting PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Not Yet Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE4
Status: Recruiting → Not Yet Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE4
-
Nov 2023 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Oct 2023 — Nov 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2023 — Oct 2023 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2021 — Mar 2023 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de la Réunion
- Centre Hospitalier de Cayenne
- Hôpital de Mayotte
- University Hospital Center of Martinique
- University Hospital of Guadeloupe
For direct contact, visit the study record on ClinicalTrials.gov .